[Study on the treatment and prognosis of lymphoplasmacytoid lymphoma: a report of 41 cases].
OBJECTIVE
To analyze the prognosis of lymphoplasmacytoid lymphoma.


METHODS
The prognosis of 41 cases of lymphoplasmacytoid lymphoma in long-term follow-up were analyzed.


RESULTS
The median survival was 39.4 months. The survival durations were significantly shorter in patients in clinical stage III , IV (P < 0.01), with B-symptoms (P < 0.05), and with bone marrow and extranodal involvements (P < 0.01). The tumor-free survival in patients received comprehensive treatment was longer than in those received chemotherapy alone (P < 0.05), but the overall survival durations between the two groups had no difference.


CONCLUSIONS
No therapeutic benefit was obtained from actively overtreatment for lymphoplasmacytoid lymphoma.
Xu
X
X
Department of Oncology and Hematology, The Second Hospital of Dandong, Dandong 118002.
Zhang
W
W
Li
L
L
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome; D008258:Waldenstrom Macroglobulinemia / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D055815:Young Adult